( E and F ) 2-way ANOVA with time and genotype as covariables, idks multiple-comparison test
The distinct features manifested by R310 6.40b and H363 6.52b are likely to be responsible for the kink formation induced by compound 2, in line with previous mutagenesis results that mutation at these two sites altered GLP-1R signaling profiles (cAMP, pERK and iCa 2+ ) 4,37
Clin Pharmacokinet 50:8198 Innzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK (2014) Metformin in patients with type 2 diabetes and kidney disease: a systematic review
Esta combinacin es objeto de estudio habitual en la investigacin bioqumica por su interaccin con los mecanismos de sealizacin peptdica y los procesos de regulacin molecular
Took a GLP-1 Drug (name brand drug / not compound version) manufactured by Novo Nordisk or Elli Lilly, 2